SCHEMBL20054243

SCHEMBL20054243

C/N=C/CCN(C)C1CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909233 0.76 EPHX2 (0.38)
SCHEMBL29955856 0.74
SCHEMBL18909349 0.72
SCHEMBL4756560 0.67
SCHEMBL15247864 0.67 KDM4E (0.40) HTR2AKDM4E
SCHEMBL95571 0.67
SCHEMBL29954517 0.67 ADH1A (0.45) KDM4E
SCHEMBL13013674 0.67 EBP (0.37) KDM4E
SCHEMBL25379709 0.65
Hydrochloric Acid SCHEMBL6609957 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed